Mercado M

Language: Spanish
References: 12
Page: 1-2
PDF size: 338.50 Kb.

ABSTRACT

One of the many confusions that the COVID-19 pandemic has generated is the idea that angiotensin converting enzyme inhibitors and angiotensin II receptors antagonists could aggravate the pulmonary damage induced by SARS-CoV-2 in elderly patients. This short communication attempts to critically analyze the scientific evidence supporting this association.

REFERENCES

1. Li G, Hu R, Zhang X. Antihypertensive treatment with ACEI/ARB of patients with Covid-19 complicated by hypertension. Hypert Res. 2020. Ahead of print.

2. Mourad JJ, Levy BI. Interaction between RAAS inhibitors and ACE2 in the context of COVID-19. Nat Rev Cardiol. 2020. Ahead of print.

3. Vadughanathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin-Angiotensin- Aldosterone system inhibitors in patients with Covid-19. N Engl J Med. 2020. Ahead of print.

4. Shamah-Levy T, Cuevas-Nasu L, Rivera-Dommarco J, Hernández-Ávila M. Encuesta Nacional de Nutrición y Salud de Medio Camino 2016. Informe final de resultados [Internet]. México: Instituto Nacional de Salud Pública/Secretaría de Salud; 31 de octubre de 2016. Disponible en https://www.gob.mx/cms/uploads /attachment/file/209093/ENSANUT.pdf

5. Borghi C, Rossi F. Role of the Renin-Angiotensin- Aldosterone system and its pharmacological inhibitors in cardiovascular diseases: Complex and critical issues. High Blood Pressure Cardiovasc Prev. 2015;22:429-44.

6. Lavoie JL, Sigmund CD. Minireview: Overview of the renin-angiotensin system—an endocrine and paracrine system. Endocrinology. 2003;144(6):2179-83. 2

7. Miller AJ, Arnold AC. The renin-angiotensin system in cardiovascular autonomic control: recent developments and clinical implications. Clin Auton Res. 2019;29:231-43. DOI: 10.1007/s10286-018- 0572-5

8. Donoghue M, Hsieh F, Baronas E, Godbout K, Gosselin M, Stagliano N, et al. A novel angiotensinconverting enzyme-related carboxypeptidase (ACE2) converts angiotensin to angiotensin 1-9. Circ Res. 2000;87:e1-9.

9. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, et al. A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS Coronavirus-induced lung injury. Nat Med. 2005;11(8):875-79.

10. Li W, Moore MJ, Vasilieva N, Sui J, Wong SK, Berne MA, et al. Angiotensin converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426(6965):450-54.

11. Epelman S, Shrestha K, Troughton RW, Francis GS, Sen S, Klein AL, et al. Soluble angiotensin converting enzyme in human heart failure: relation with myocardial function and clinical outcomes. J Card Fail. 2009;15(7):565-71.

12. Furuhashi M, Moniwa N, Mita T, Fuseya T, Ishimura S, Ohno K, et al. Urinary angiotensinconverting enzyme 2 in hypertensive patients maybe increased by Olmesartan, an angiotensin II receptor blocker. Am J Hypertens. 2015;28(1): 15-21.